Mylan Launches First-Filer Maxalt MLT Copy

January 23, 2013
Mylan has begun marketing its generic versions of Merck migraine drug Maxalt MLT, kicking off the company’s 180 days of generic exclusivity as the first patent challenger. The generic-drug maker will offer the 5-mg (base) and 10-mg (base) versions of Maxalt MLT (rizatriptan benzoate orally disintegrating tablets).
Generic Line